Nature Neuroscience

Nature Neuroscience (nature-neuroscience)

Journal positioning

Nature Neuroscience, published by Springer Nature, is among the most selective journals in the field, publishing conceptual advances in neuroscience across all scales — from molecules and synapses to circuits, systems, and behavior. It sits one tier below Nature in the Springer Nature hierarchy but above specialty society journals, and commands the full editorial-triage culture of the Nature family: most submissions are triaged without review based on significance and conceptual novelty alone. The readership spans the whole neuroscience community, so a paper must matter beyond its model organism, brain region, or technical niche. This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on nature.com/neuro.

When to trigger

• The author names Nature Neuroscience or Nat Neurosci as the target venue.
• A neuroscience manuscript represents a clear conceptual advance and the author is calibrating among Nature Neuroscience, Neuron, or Nature.
• A study uses a novel technology (two-photon imaging, large-scale electrophysiology, cryo-EM of neural proteins, spatial transcriptomics) to answer a field-defining circuit or behavioral question.
• The author needs Nature Neuroscience's triage criteria, significance bar, and a credible reroute within neuroscience.

Scope & topic fit

• Circuit neuroscience: neural circuit mechanisms underlying behavior, decision-making, memory, and perception — particularly where circuit dissection connects to behavioral output.
• Cellular and molecular neuroscience: synapse biology, neuronal development, glial biology, and axon-dendrite mechanisms with field-advancing conceptual reach.
• Systems and cognitive neuroscience: large-scale neural dynamics, coding, and computation — only when the biological question is central and the advance is conceptual, not purely methodological.
• Disease-relevant neuroscience: mechanism-of-disease studies in neurological or psychiatric conditions are welcome when the basic-science insight is primary and clinically actionable findings are secondary.
• New technologies are publishable here when the tool enables a field-shifting biological discovery, not as a pure methods/tool paper.

Method & evidence bar

• Single-paper conceptual advance: the contribution must shift the field's understanding of a core neural principle, not just add a data point to an established narrative.
• Multi-scale validation is expected for circuit papers: anatomy + physiology + behavior, or equivalent combinatorial evidence.
• Genetic tools (optogenetics, chemogenetics, conditional KO, AAV-mediated manipulation) are now standard; they must be properly controlled (opsin-negative controls, off-target assessment).
• Human neuroscience (fMRI, EEG, MEG, human electrophysiology) is publishable when the neuroscientific question and design are rigorous — pure cognitive psychology without neural mechanism does not fit.
• Nature family reporting requirements: Life Sciences Reporting Summary must be completed; statistics (sample sizes, tests, exact n values) reported per Nature guidelines.

Structure & house style

• Nature Neuroscience uses the standard Nature family format: an unstructured abstract, main text with Results and Discussion integrated or separated, a short Methods section in the main paper, and extended Methods in supplemental.
• Extended Data (up to 10 extended data figure panels) carries additional experimental validation; Supplementary Information is for large datasets, code, and ancillary materials.
• The abstract must convey the conceptual advance — not just the technical approach — in the first two sentences; the final sentence should state the broader implication.
• Significance statement or editor's summary may be requested for press-release consideration.
• Nature family requires a data availability statement and a code availability statement with repository links.

Official-submission checklist

• Before giving submission-ready advice, read ../../resources/source-basis.md and ../../resources/official-source-map.md; start from the official source anchors for this journal family, then cite the current journal-specific page you checked.
• Search the live site for "Nature Neuroscience author information" and follow the current Springer Nature version.
• Re-check article types: Articles (standard), Letters have been phased out in many Nature titles — confirm current format and length expectations.
• Complete the Life Sciences Reporting Summary: this is mandatory and covers experimental design, sample sizes, randomization, blinding, statistical tests, and inclusion/exclusion criteria.
• Confirm data availability: raw data deposition (electrophysiology, imaging, sequencing) in appropriate public repositories with accession numbers.
• Verify code availability for any custom analysis; confirm Nature family AI-use policy and competing-interests disclosure.
• Check preprint policy: Nature journals generally allow preposting on bioRxiv — verify current details.
• If the live official instructions conflict with this skill, the official instructions win.

Pre-submission self-check

• One sentence stating the conceptual principle advanced — not the technique used or the brain region studied.
• The framing positions the paper against the two or three most recent advances in Nature Neuroscience, Neuron, or Nature that define the open question.
• Multi-scale evidence is assembled: the central claim is supported by anatomical, physiological, and behavioral (or equivalent) convergent data.
• Life Sciences Reporting Summary is drafted; all n values, statistical tests, and blinding/randomization procedures are specified.
• Extended Data is organized to carry the full validation story independently of the main figures.

Common desk-reject triggers

• Incremental advances in an established circuit or behavioral paradigm without a new conceptual principle — "adding another piece" to a well-characterized circuit does not meet the triage threshold.
• Technology-centric papers that demonstrate a new method (new virus, new opsin, new probe) without using it to answer a field-defining biological question.
• Studies confined to a single species/brain region where the advance is described but not explicitly generalized to a broader neural principle interpretable by the whole field.
• Missing or inadequate Life Sciences Reporting Summary — Nature editorial offices check for this at submission and flag it before sending to reviewers.
• Human fMRI or psychophysics studies without a clear mechanistic neural hypothesis and corresponding neural data; behavioral-only studies belong at Nature Human Behaviour.
• Descriptive anatomical or transcriptomic characterizations (cell-type catalogues) without functional dissection of circuit or behavioral relevance.

Re-routing decision

• Equally high-impact neuroscience with broader multidisciplinary significance → nature or science.
• Outstanding neuroscience but editorial threshold for Nature Neuroscience not cleared → neuron (Cell Press flagship) or current-biology.
• Human behavioral or cognitive science (no direct neural data) → nature-human-behaviour or Psychological Science.
• Disease-mechanism framing is primary → nature-medicine or molecular-psychiatry.

Output format

[Fit] High / Medium / Low (one-line reason)
[Target] Nature Neuroscience
[Topic tags] <2–3 closest topics>
[Method/evidence] <does the conceptual advance and multi-scale evidence clear the Nature Neuroscience triage bar?>
[Top risk] <the single most likely reason for rejection or triage>
[Official items to re-check] <Reporting Summary / extended data / data deposition / code / article type / preprint policy>
[Re-route suggestion] <if not a fit, a better-matched venue>